-+ 0.00%
-+ 0.00%
-+ 0.00%

*VTv Therapeutics: Topline Phase 3 Data for Cadisegliatin Expected in 2H 2026 >VTVT

Dow Jones·05/15/2025 20:15:00

Please log in to view news